Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.
about
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancerVariation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study.Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer NetworkPostmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process.A community breast center report card determined by participation in the national quality measures for breast centers program.Can we measure the quality of breast surgical care?Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer.Receipt of recommended radiation therapy among rural and urban cancer patients.Increased utilization of postmastectomy radiotherapy in the United States from 2003 to 2011 in patients with one to three tumor positive nodes.Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers.Moving toward appropriateness of breast cancer care: a balanced act to redefine the scope of standard of care.Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women.Receipt of locoregional therapy among young women with breast cancer.Post-mastectomy Radiation: Should Subtype Factor into the Decision?
P2860
Q33739253-63637F69-B5D3-4325-AA6D-E9F0926AA149Q33824842-958CE91E-1372-472A-AB5C-BA2FE5315829Q33897593-2DCF6946-D8D8-4DAE-BDDB-5F2663835306Q35688776-0F4F9B83-6B6F-4D12-AD5C-8BDED28B8EA3Q36726996-94BDB639-57B7-464C-ABA8-BEE117131D17Q37528386-E5A8825D-AADA-4F83-BDFD-670094C73305Q37781080-EFC7282A-5A1B-4C2F-A758-01ADAE67EF2FQ37921658-2F2C7E07-93A3-4FAB-863B-6E4A796CAABEQ40002147-4C2E7F9A-6A44-4327-88EB-E21FE68DEE5BQ40067447-D69B28C6-50FD-47AF-A019-3BF12624C7E2Q40408664-CBE712A5-D2EC-4E8F-86C3-BF587D5542D0Q40915150-3CC1A3CD-415A-4571-85F8-3817A4FB46D2Q42369324-AF8F79A9-3740-4BAA-92B1-27CED927CA82Q44588739-A9A46B15-9630-424A-8C8A-AEE20086D399Q46659566-481827AA-AAD2-4587-A9F7-211D19EEB19EQ53139278-A234B823-72B8-4E26-A3E4-5D034AD3DAEA
P2860
Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factors associated with guidel ...... comprehensive cancer network.
@en
Factors associated with guidel ...... comprehensive cancer network.
@nl
type
label
Factors associated with guidel ...... comprehensive cancer network.
@en
Factors associated with guidel ...... comprehensive cancer network.
@nl
prefLabel
Factors associated with guidel ...... comprehensive cancer network.
@en
Factors associated with guidel ...... comprehensive cancer network.
@nl
P2093
P2860
P1476
Factors associated with guidel ...... comprehensive cancer network.
@en
P2093
Jane C Weeks
John L Wilson
Joyce C Niland
Melissa E Hughes
Michael A Bookman
Rebecca A Ottesen
Richard L Theriault
Rinaa S Punglia
Stephen B Edge
P2860
P304
P356
10.1016/J.IJROBP.2008.03.020
P407
P577
2008-05-28T00:00:00Z